vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $30.5M, roughly 1.6× FGI Industries Ltd.). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -8.6%, a 3.9% gap on every dollar of revenue. On growth, FGI Industries Ltd. posted the faster year-over-year revenue change (-14.4% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $2.3M). Over the past eight quarters, FGI Industries Ltd.'s revenue compounded faster (-0.5% CAGR vs -20.2%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FGI vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $47.7M |
| Net Profit | $-2.6M | $-2.3M |
| Gross Margin | 26.7% | — |
| Operating Margin | -2.2% | 14.3% |
| Net Margin | -8.6% | -4.8% |
| Revenue YoY | -14.4% | -47.3% |
| Net Profit YoY | -553.1% | -200.9% |
| EPS (diluted) | $-1.63 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $47.7M | ||
| Q3 25 | $35.8M | $122.1M | ||
| Q2 25 | $31.0M | $85.2M | ||
| Q1 25 | $33.2M | $41.1M | ||
| Q4 24 | $35.6M | $90.5M | ||
| Q3 24 | $36.1M | $91.6M | ||
| Q2 24 | $29.4M | $94.4M | ||
| Q1 24 | $30.8M | $74.9M |
| Q4 25 | $-2.6M | $-2.3M | ||
| Q3 25 | $-1.7M | $40.1M | ||
| Q2 25 | $-1.2M | $23.6M | ||
| Q1 25 | $-629.1K | $-37.4M | ||
| Q4 24 | $-402.3K | $2.3M | ||
| Q3 24 | $-550.1K | $3.6M | ||
| Q2 24 | $163.6K | $-860.0K | ||
| Q1 24 | $-412.2K | $-4.2M |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 27.4% | — |
| Q4 25 | -2.2% | 14.3% | ||
| Q3 25 | 1.0% | 61.8% | ||
| Q2 25 | -2.7% | 53.2% | ||
| Q1 25 | -3.9% | -70.7% | ||
| Q4 24 | -3.5% | 34.8% | ||
| Q3 24 | -0.2% | 28.0% | ||
| Q2 24 | -1.5% | 26.5% | ||
| Q1 24 | -1.0% | 14.7% |
| Q4 25 | -8.6% | -4.8% | ||
| Q3 25 | -4.6% | 32.8% | ||
| Q2 25 | -4.0% | 27.7% | ||
| Q1 25 | -1.9% | -90.9% | ||
| Q4 24 | -1.1% | 2.5% | ||
| Q3 24 | -1.5% | 4.0% | ||
| Q2 24 | 0.6% | -0.9% | ||
| Q1 24 | -1.3% | -5.6% |
| Q4 25 | $-1.63 | $0.01 | ||
| Q3 25 | $-0.86 | $0.23 | ||
| Q2 25 | $-0.64 | $0.14 | ||
| Q1 25 | $-0.07 | $-0.23 | ||
| Q4 24 | $-0.38 | $0.03 | ||
| Q3 24 | $-0.29 | $0.02 | ||
| Q2 24 | $0.08 | $-0.01 | ||
| Q1 24 | $-0.04 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.3M | $-261.8M |
| Total Assets | $69.5M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $215.5M | ||
| Q3 25 | $1.9M | $140.4M | ||
| Q2 25 | $2.5M | $92.9M | ||
| Q1 25 | $1.2M | $108.5M | ||
| Q4 24 | $4.6M | $88.6M | ||
| Q3 24 | $3.0M | $88.2M | ||
| Q2 24 | $1.3M | $105.5M | ||
| Q1 24 | $3.3M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $17.3M | $-261.8M | ||
| Q3 25 | $19.7M | $-264.2M | ||
| Q2 25 | $21.3M | $-308.2M | ||
| Q1 25 | $21.8M | $-334.1M | ||
| Q4 24 | $22.3M | $-301.3M | ||
| Q3 24 | $23.5M | $-311.3M | ||
| Q2 24 | $23.8M | $-321.7M | ||
| Q1 24 | $23.9M | $-330.5M |
| Q4 25 | $69.5M | $396.9M | ||
| Q3 25 | $73.0M | $396.1M | ||
| Q2 25 | $71.7M | $342.9M | ||
| Q1 25 | $68.5M | $327.2M | ||
| Q4 24 | $75.5M | $350.9M | ||
| Q3 24 | $74.7M | $389.5M | ||
| Q2 24 | $69.9M | $395.6M | ||
| Q1 24 | $68.6M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $74.6M |
| Free Cash FlowOCF − Capex | $2.3M | $74.6M |
| FCF MarginFCF / Revenue | 7.5% | 156.3% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $74.6M | ||
| Q3 25 | $-1.9M | $47.6M | ||
| Q2 25 | $7.6M | $-15.1M | ||
| Q1 25 | $-7.4M | $20.0M | ||
| Q4 24 | $617.4K | $15.2M | ||
| Q3 24 | $-915.0K | $9.9M | ||
| Q2 24 | $862.1K | $33.5M | ||
| Q1 24 | $-8.0M | $45.0M |
| Q4 25 | $2.3M | $74.6M | ||
| Q3 25 | $-2.1M | $47.6M | ||
| Q2 25 | $7.4M | $-15.1M | ||
| Q1 25 | $-7.7M | $19.9M | ||
| Q4 24 | $-214.1K | — | ||
| Q3 24 | $-1.1M | $9.9M | ||
| Q2 24 | $281.5K | $33.4M | ||
| Q1 24 | $-8.6M | $44.9M |
| Q4 25 | 7.5% | 156.3% | ||
| Q3 25 | -5.9% | 39.0% | ||
| Q2 25 | 23.8% | -17.7% | ||
| Q1 25 | -23.3% | 48.4% | ||
| Q4 24 | -0.6% | — | ||
| Q3 24 | -3.0% | 10.8% | ||
| Q2 24 | 1.0% | 35.4% | ||
| Q1 24 | -28.0% | 60.0% |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 1.1% | 0.1% | ||
| Q4 24 | 2.3% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 2.0% | 0.1% | ||
| Q1 24 | 2.0% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
IRWD
Segment breakdown not available.
